Point72 Asia Singapore Pte. Ltd. Reduces Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Point72 Asia Singapore Pte. Ltd. reduced its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 71.9% during the second quarter, Holdings Channel reports. The firm owned 467 shares of the company’s stock after selling 1,195 shares during the quarter. Point72 Asia Singapore Pte. Ltd.’s holdings in Addus HomeCare were worth $54,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. UMB Bank n.a. grew its holdings in shares of Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the period. Quest Partners LLC purchased a new position in shares of Addus HomeCare in the 2nd quarter valued at approximately $31,000. EntryPoint Capital LLC bought a new stake in shares of Addus HomeCare during the first quarter valued at approximately $44,000. Innealta Capital LLC purchased a new stake in Addus HomeCare in the second quarter worth $44,000. Finally, GAMMA Investing LLC raised its holdings in Addus HomeCare by 40.8% in the first quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock worth $57,000 after purchasing an additional 161 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Insider Transactions at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the transaction, the director now owns 3,866 shares in the company, valued at $502,695.98. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the sale, the director now directly owns 3,866 shares in the company, valued at approximately $502,695.98. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock worth $3,050,082 over the last three months. 4.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ADUS has been the topic of a number of recent research reports. Oppenheimer upped their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Royal Bank of Canada reiterated an “outperform” rating and set a $141.00 target price on shares of Addus HomeCare in a report on Tuesday, September 3rd. Macquarie began coverage on Addus HomeCare in a research report on Friday, June 28th. They issued an “outperform” rating and a $136.00 price target on the stock. Finally, Stephens reiterated an “overweight” rating and set a $138.00 price objective on shares of Addus HomeCare in a research note on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating and eight have given a buy rating to the stock. According to data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and an average target price of $128.29.

Addus HomeCare Stock Up 1.6 %

Shares of ADUS opened at $133.03 on Tuesday. The company has a market capitalization of $2.41 billion, a P/E ratio of 33.01, a price-to-earnings-growth ratio of 2.40 and a beta of 1.04. Addus HomeCare Co. has a twelve month low of $78.35 and a twelve month high of $136.12. The firm has a 50 day moving average of $128.48 and a 200 day moving average of $115.67.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million during the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.94 EPS. On average, sell-side analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.